Danielle Almeida has a BSc degree in Biological Sciences by Universidade Gama Filho (Brasil - Rio de Janeiro) and a MSc degree in Health Surveillance by Fiocruz (Brasil - Rio de Janeiro). She is currently doing her PhD in Biology, which is focused on discovering new ways to increase the anti-tumour therapeutic potential of human dendritic cells in combination with immune checkpoint blockers.